Home/Filings/4/0001493152-22-021940
4//SEC Filing

Karkus Ted William 4

Accession 0001493152-22-021940

CIK 0000868278other

Filed

Aug 9, 8:00 PM ET

Accepted

Aug 10, 9:23 PM ET

Size

9.8 KB

Accession

0001493152-22-021940

Insider Transaction Report

Form 4
Period: 2022-08-10
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.005

    2022-08-10$0.60/sh+600,000$360,0003,105,214 total
  • Tax Payment

    Common Stock, par value $0.005

    2022-08-10$10.84/sh316,605$3,431,9982,788,609 total
  • Exercise/Conversion

    Option (right to buy)

    2022-08-10600,0001,700,000 total
    Exercise: $0.60Exp: 2023-02-22Common Stock (600,000 underlying)
Holdings
  • Common Stock, par value $0.005

    (indirect: By Son)
    100,000
Footnotes (2)
  • [F1]On August 10, 2022, the Reporting Person acquired net 283,395 shares of common stock upon the exercise of stock options to purchase 600,000 shares of common stock, less 316,605 shares of common stock withheld to cover the exercise price and applicable taxes.
  • [F2]The option vested in 35 equal monthly installments of 63,888 shares on the 1st day of each month beginning on March 1, 2018 (the "Initial Vesting Date"), and one monthly installment of 63,920 shares on the 1st day of the 36th month following the Initial Vesting Date, as described in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of February 19, 2018.

Documents

1 file

Issuer

ProPhase Labs, Inc.

CIK 0000868278

Entity typeother

Related Parties

1
  • filerCIK 0001457896

Filing Metadata

Form type
4
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 9:23 PM ET
Size
9.8 KB